Siemens Healthineers Sets Medium-Term Earnings, Revenue Growth Targets
17 Novembro 2021 - 04:36AM
Dow Jones News
By Cecilia Butini
Siemens Healthineers AG on Wednesday set revenue and
earnings-per-share growth targets for fiscal years 2023 to 2025 as
it launched the third phase of its strategy through 2025.
The German medical-equipment maker said it expects revenue
growth of 6% to 8% annually for fiscal years 2023 to 2025, while
adjusted earnings-per-share growth is expected at 12% to 15% a year
based on broad-based margin expansion.
The goals are part of the latest phase of the company's
strategy, which begins in fiscal year 2022 after Siemens
Healthineers said it completed the previous plan a year ahead of
schedule.
Siemens Healthineers said it expects research-and-development
spending at 8% to 9% of revenue, and selling, general and
administrative expenses at 15% to 17%.
Synergy targets from the acquisition of Varian are going to be
raised to more than 350 million euros ($396.3 million) by 2025,
according to the company. It added that it will partially reinvest
cost synergies to generate future revenue synergies, and that those
will be effective to profit-and-loss primarily in fiscal 2024 and
2025.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
November 17, 2021 02:21 ET (07:21 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Siemens Healthineers (TG:SHL)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Siemens Healthineers (TG:SHL)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024